Compagnie Lombard Odier SCmA’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History
Bought
Maintained
Sold
Compagnie Lombard Odier SCmA's RPTP Position: Q4 2016 in Review
Compagnie Lombard Odier SCmA sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 50,000 shares — an estimated $448K sold.
Compagnie Lombard Odier SCmA first reported a position in RPTP in Q4 2013 and held it in 12 quarters. The position peaked at $1.03M in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.
- Compagnie Lombard Odier SCmA reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
- Compagnie Lombard Odier SCmA sold 50,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $448K.
- Compagnie Lombard Odier SCmA first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2013 and held it in 12 quarters.
- Compagnie Lombard Odier SCmA's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1.03M in Q2 2015.
- 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.
Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2016, filed 14 Feb 2017.